Trial Profile
A Randomized, Cross-over Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Haemodialysis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Genzyme Corporation
- 20 May 2014 New trial record